IRIS

Cost-effectiveness of adding zoledronic acid to endocrine therapy in premenopausal women with hormone-responsive early breast cancer in Portugal, Spain, and Italy, based on the ABCSG-12 Study.

GERZELI, SIMONE ANTONIO GIUSEPPE;
2010-01-01
2010
The Health Care Sciences & Services category includes resources on health services, hospital administration, health-care management, health-care financing, health policy and planning, health education, history of medicine, medical ethics, palliative care and nursing, integrative and complementary medicine, and nursing.
EUROPEAN JOURNAL OF CANCER. SUPPLEMENT
Sì, ma tipo non specificato
Inglese
contributo
22nd EORTC-NCI-AACR symposium on “Molecular targets and Cancer Therapeutics”
16 - 19 November 2010
Berlin
Internazionale
STAMPA
8
63
64
COST-EFFECTIVENESS; BREAST CANCER; ZOLEDRONIC ACID
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B75GT-4YPG1M9-1P&_user=3719172&_coverDate=03%2F31%2F2010&_rdoc=1&_fmt=high&_orig=gateway&_origin=gateway&_sort=d&_docanchor=&view=c&_acct=C000061210&_version=1&_urlVersion=0&_userid=3719172&md5=b4ff5d796dc8e6eaebbd47e8d1be5e8d&searchtype=a
none
Delea, Te; Tanaja, C; Kaura, S; Sternini, P; Gerzeli, SIMONE ANTONIO GIUSEPPE; Gnant, M.
273
info:eu-repo/semantics/conferenceObject
6
4 Contributo in Atti di Convegno (Proceeding)::4.1 Contributo in Atti di convegno
4.1 Contributo in Atti di convegno
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/226129
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact